Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Nelova (Nilotinib) 200mg Tablets
Nelova (Nilotinib) 200mg Tablets, manufactured by Sun Pharmaceuticals Ltd., is a specialized medication designed for the treatment of blood cancer, offering targeted therapy for specific types of leukemia.
Uses of Nelova (Nilotinib) 200mg Tablets
Nelova (Nilotinib) 200mg Tablets are indicated for:
Treatment of chronic myeloid leukemia (CML) in adults.
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults and pediatric patients.
Benefits of Nelova (Nilotinib) 200mg Tablets
Targets and inhibits specific proteins responsible for the growth and survival of cancer cells.
Improves progression-free survival and overall survival rates in patients with CML and Ph+ ALL.
Provides a well-tolerated oral treatment option, enhancing convenience and adherence to therapy.
Mechanism of Action of Nelova (Nilotinib) 200mg Tablets
Nelova (Nilotinib) 200mg Tablets contain nilotinib, a tyrosine kinase inhibitor that selectively inhibits BCR-ABL, c-KIT, and PDGFR kinases. By blocking these signaling pathways, nilotinib prevents the proliferation and survival of leukemia cells, leading to disease regression and improved clinical outcomes.
Beside this well also export in other countries